Search
for
Sort by
Research 631–660 of 1000+
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives
- Azelaic Acid in Dermatology: A Review of Its Mechanism of Action
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- THE IDENTIFICATION OF MOLECULAR MECHANISMS FROM BIOACTIVE COMPOUNDS IN Sansevieria trifasciata PLANT AS ANTI-ALOPECIA: In-Silico APPROACH